Efficacy and safety of Duodopa in patients with advanced Parkinson's Disease

Next Previous
Trial Profile

Efficacy and safety of Duodopa in patients with advanced Parkinson's Disease

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms GLORIA

    • Most Recent Events

    • 27 Jun 2017 Results of a post-hoc analysis evaluating the influence of baseline characteristics on QOL and Activities of Daily Living (ADL) presented at the 3rd Congress of the European Academy of Neurology
    • 28 Apr 2017 Results of a post-hoc analysis assessing the effect of age and disease duration on quality of life outcomes, presented at the 69th Annual Meeting of the American Academy of Neurology
    • 28 Apr 2017 Final results assessing long-term safety and efficacy in subgroup of patients (n=257) with dyskinesia at baselinepresented at the 69th Annual Meeting of the American Academy of Neurology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top